Clinical trial
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With…
NCT00242541 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00242541 |
|---|---|
| Title | Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas |
| Official title | Open Label Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Octreotide acetate |
| Enrollment | 50 |
| Start date | Mar 1, 2003 |
| Primary completion | Aug 1, 2005 |
| First posted | Oct 20, 2005 |
| Last update posted | Apr 26, 2012 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: